Serving guides
Can you take too much CBD?
Written by: Author pendingReviewed by: Reviewer pendingUpdated:
Yes: higher doses bring more side effects, though no death from CBD alone has been documented. A Phase I trial gave healthy adults single doses up to 6000 mg and reported only mild to moderate effects, most often diarrhea and sleepiness (CNS Drugs, 2018). The real ceiling is drug interactions and liver enzyme changes at sustained high doses.
"Too much" means different things: enough to cause side effects, enough to be dangerous, or enough to be wasted. CBD clears the second bar easily and the first bar at doses most consumers never approach. The third is where the money goes.
What happened in the highest-dose human trials?
The widest dose range in a controlled setting comes from a Phase I trial published in CNS Drugs. Healthy adults received single doses of 1500, 3000, 4500 or 6000 mg of purified CBD, or 750 to 1500 mg twice daily for a week. Every participant completed the study. All adverse events were mild or moderate, with no serious events and no discontinuations; the most common were diarrhea and somnolence. Exposure rose less than proportionally with dose, meaning the body absorbed a smaller fraction as the dose climbed.
For context, 6000 mg is 240 standard 25 mg softgels in one sitting. The World Health Organization's 2018 critical review reached the summary most clinicians cite: "CBD is generally well tolerated with a good safety profile," adding that reported adverse effects may stem from interactions between CBD and a patient's existing drugs.
Where does the FDA drug label set the ceiling?
The one FDA-reviewed CBD product caps dosing at 10 mg/kg twice daily, or 20 mg/kg per day, which is 1,400 mg daily for a 70 kg adult. The label notes the higher dose produced somewhat more effect than the 10 mg/kg per day maintenance dose but with more adverse reactions. The label also carries warnings that matter at sustained high intake: transaminase (liver enzyme) elevations, which is why the label requires baseline liver tests, and somnolence and sedation. NCCIH's consumer page lists decreased alertness, mood changes, decreased appetite and gastrointestinal effects as the side effects to expect, and notes that CBD has been associated with liver effects and interactions with other drugs.
Retail servings of 10 to 50 mg are a small fraction of those prescription doses. The liver signal in the prescription data appeared at hundreds to thousands of milligrams per day, often alongside other drugs.
What is the actual risk at high doses?
Drug interactions, more than the CBD itself. A 2018 review in the British Journal of Clinical Pharmacology notes that CBD and THC are both metabolized by the liver, creating interaction potential with other drugs that use the same enzymes; the review cites CBD's inhibition of clobazam metabolism as the documented case. Raising the CBD dose raises the degree of that inhibition. Anyone on prescription drugs, blood thinners in particular, has a lower practical ceiling than a healthy adult taking nothing else.
Animal data point the same direction. The Merck Veterinary Manual reports that acute oral overdoses up to 62 mg/kg in dogs produced diarrhea, that cats tolerated up to 80 mg/kg with no CBD-related signs, and that chronic dosing in dogs caused transient liver enzyme elevations. Across species the pattern is gastrointestinal upset first, liver enzymes with sustained use, and no documented lethal dose.
What does "too much" look like for a consumer?
Mostly, wasted money. Because absorption rises less than proportionally with dose, doubling a serving does not double blood levels. The practical signs of overshooting are the same ones the trials recorded: loose stool, drowsiness during the day and reduced appetite. If those appear, the serving is too high for that person and the fix is to reduce it. Daytime drowsiness is also the reason not to drive after a first large dose.
This page is general information, not personalized guidance.
General information, not personalized guidance.
Sources
- A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects CNS Drugs, via PubMed (accessed 2026-10-13)
- Cannabidiol (CBD) Critical Review Report World Health Organization, Expert Committee on Drug Dependence (accessed 2026-10-13)
- EPIDIOLEX (cannabidiol) oral solution, prescribing information U.S. Food and Drug Administration (accessed 2026-10-13)
- The pharmacokinetics and the pharmacodynamics of cannabinoids British Journal of Clinical Pharmacology, via PubMed (accessed 2026-10-13)
- Cannabis (Marijuana) and Cannabinoids: What You Need To Know NCCIH, National Institutes of Health (accessed 2026-10-13)
- Toxicosis in Dogs and Cats From Cannabidiol (CBD) Merck Veterinary Manual (accessed 2026-10-13)
Related questions
How much CBD should a first-time user take?
There is no established consumer dose. Pharmacology reviews recommend a "start low and go slow" approach (Br J Clin Pharmacol, 2018). In practice that means beginning with a...
How long does CBD stay in your system?
It depends on how often it is taken. A systematic review found single oral doses cleared with half-lives of about 1 to 2 hours in blood, while chronic oral dosing produced...
How many milligrams of CBD are in one dropper?
Divide the label total by the bottle volume. A 1500 mg bottle holding 30 mL delivers 50 mg per 1 mL dropper and 25 mg per half dropper; the same 1500 mg in 60 mL is 25 mg per...
Is CBD safe for dogs? What the published studies measured
The published canine studies report CBD as well tolerated at 2 mg/kg twice daily for up to 12 weeks, with loose stool the most common effect and liver enzyme elevations the main...